Noun
sitagliptin (uncountable)
(pharmacology) A hypoglycemic drug taken orally in the form of its phosphate C16H15F6N5O·H3PO4·H2O in the treatment of type 2 diabetes. It acts by inhibiting the degradation of incretins, which results in increased secretion of insulin by the pancreas. It is marketed under the trademark Januvia and when used in combination with metformin, under the trademark Janumet.
The adjusted mean change from baseline in body weight was -0.3 kg in patients receiving sitagliptin with metformin immediate-release and insulin and -0.2 kg in patients receiving placebo with metformin immediate-release and insulin. Source: Internet
Ertugliflozin and sitagliptin are present in the milk of lactating rats (see ). Source: Internet
STEGLUJAN 15 mg/100 mg: ertugliflozin 15 mg and sitagliptin 100 mg tablets are brown, almond-shaped, debossed with “555” on one side and plain on the other side. Source: Internet
It is not known whether sitagliptin is excreted in human milk. Source: Internet
What are the possible side effects of metformin and sitagliptin (Janumet, Janumet XR)? Source: Internet
The patentee, MSD, which imports and markets Sitagliptin as Januvia, has also entered into an agreement with Sun Pharma Laboratories, which sells Sitagliptin under the brand name, Istavel. Source: Internet